Isogenix

Developer of precision therapies targeting protein isoforms for neuromuscular and neurological diseases

placeOxford, England, United Kingdom calendar_todayFounded 2023 language isogenixtx.com

Registered entities

Social engagement

Social engagement: 975 social following, 3 posts in the last 12 months — below the industry typical range.

Investor mix

2 investors on record.

Investor typeCountShare
Venture capital150%
Other / undisclosed150%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

5 Feb 2026 · Senior Scientist · Oxford, England

23 Jan 2026 · Bioinformatician

9 Sep 2025 · Principal Scientist · Oxford, England

Based on job postings tracked across public sources.

Coming soon